Clinical Trials Logo

Myofascial Trigger Point Pain clinical trials

View clinical trials related to Myofascial Trigger Point Pain.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT06029413 Enrolling by invitation - Clinical trials for Trigger Point Pain, Myofascial

Myo vs. Myofascial Injection for Myofascial Trigger Points

Start date: September 26, 2023
Phase: N/A
Study type: Interventional

In this study, the effectiveness of two different application methods that can be used in myofascial trigger point injection treatment will be compared.

NCT ID: NCT05816161 Enrolling by invitation - Clinical trials for Myofascial Trigger Point Pain

Integrated Neuromuscular Inhibition Technique and Myofascial Release on Cervical Range of Motion and Dysfunction

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

to findout the improvement by Integrated Neuromuscular Inhibition Technique and Myofascial Release on Cervical Range of Motion and Dysfunction

NCT ID: NCT04732507 Enrolling by invitation - Myofascial Pain Clinical Trials

Investigating the Minimum Number of Needling Required to Optimize Trigger Point Injections Outcome

Start date: April 20, 2021
Phase: Phase 2
Study type: Interventional

Myofascial pain is a common condition in which patients may experience severe chronic pain. The source of this pain is typically the soft tissue. Current methods to address myofascial pain include a procedure called Trigger point Injections. This method involves identifying the areas of muscles that are causing the pain. The most common way to perform trigger point injection involves infiltrating the muscle with local anesthetics and then repeatedly passing the numbing needle in and out of the muscles (needling). This procedure is successful for most patients. However, there is great variability in the way needling is done. Some pain physicians perform 1-2 needle passes while other pain physicians may exceed 20 passes. There are currently no guidelines as to the number or amount of needle passes needed to achieve pain control. Furthermore, there is no study or research to shed light on the relationship between the number of needles passes and the degree and duration of pain relief coupled with patients' satisfaction. This study is proposed to address this gap in knowledge. It is a prospective and randomized clinical trial that follows the standard of care. The investigators will recruit patients from The University-Banner Medical Center at Tucson, Arizona chronic pain clinic who are candidates for trigger point injections. The participants will be randomized into 3 different groups. Group one will receive 2 needle passes per identified trigger point. Group two will receive ten needle passes per identified trigger point. Group three will receive twenty needle passes per identified trigger point. The investigators will analyze the data to understand the relationship between the number of needles passes and the degree of pain relief, improved functional capacity, and patients' satisfaction.

NCT ID: NCT03941054 Enrolling by invitation - Clinical trials for Myofascial Trigger Point Pain

Myosfascial Trigger-Points and Effects on Neuromuscular Response

Start date: May 2, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to analyze the effects of the treatment of the Myosfascial Trigger-Points detected in the gastrocnemius muscles on the neuromuscular response.